Metropolitan Life Insurance Company (MetLife)’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-26,763
Closed -$66.9K 2786
2021
Q4
$66.9K Buy
26,763
+4,410
+20% +$11K ﹤0.01% 2657
2021
Q3
$114K Buy
22,353
+2,133
+11% +$10.9K ﹤0.01% 2450
2021
Q2
$168K Sell
20,220
-3,564
-15% -$29.6K ﹤0.01% 2277
2021
Q1
$207K Buy
23,784
+841
+4% +$7.33K ﹤0.01% 1999
2020
Q4
$249K Sell
22,943
-4,658
-17% -$50.6K ﹤0.01% 1793
2020
Q3
$329K Hold
27,601
0.01% 1484
2020
Q2
$443K Buy
27,601
+4,252
+18% +$68.3K 0.01% 1300
2020
Q1
$362K Sell
23,349
-2,128
-8% -$33K 0.01% 1240
2019
Q4
$627K Sell
25,477
-729
-3% -$17.9K 0.01% 1186
2019
Q3
$270K Buy
26,206
+4,799
+22% +$49.5K ﹤0.01% 1668
2019
Q2
$269K Buy
21,407
+1,837
+9% +$23.1K ﹤0.01% 1690
2019
Q1
$242K Buy
19,570
+3,029
+18% +$37.5K ﹤0.01% 1775
2018
Q4
$102K Hold
16,541
﹤0.01% 2255
2018
Q3
$175K Hold
16,541
﹤0.01% 2087
2018
Q2
$224K Buy
16,541
+670
+4% +$9.08K ﹤0.01% 1873
2018
Q1
$282K Hold
15,871
﹤0.01% 1661
2017
Q4
$199K Sell
15,871
-14,809
-48% -$186K ﹤0.01% 1913
2017
Q3
$584K Hold
30,680
﹤0.01% 1580
2017
Q2
$463K Hold
30,680
﹤0.01% 1747
2017
Q1
$526K Hold
30,680
﹤0.01% 1615
2016
Q4
$371K Buy
30,680
+3,269
+12% +$39.5K ﹤0.01% 1931
2016
Q3
$270K Sell
27,411
-3,674
-12% -$36.2K ﹤0.01% 2140
2016
Q2
$318K Hold
31,085
﹤0.01% 1993
2016
Q1
$377K Buy
31,085
+10,491
+51% +$127K ﹤0.01% 1765
2015
Q4
$330K Hold
20,594
﹤0.01% 1902
2015
Q3
$265K Sell
20,594
-647
-3% -$8.33K ﹤0.01% 2081
2015
Q2
$510K Buy
21,241
+10,959
+107% +$263K ﹤0.01% 1731
2015
Q1
$193K Hold
10,282
﹤0.01% 2077
2014
Q4
$194K Hold
10,282
﹤0.01% 2438
2014
Q3
$279K Hold
10,282
﹤0.01% 2136
2014
Q2
$320K Buy
+10,282
New +$320K ﹤0.01% 2150
2013
Q4
Sell
-4,154
Closed -$167K 2765
2013
Q3
$167K Sell
4,154
-3,427
-45% -$138K ﹤0.01% 2550
2013
Q2
$213K Buy
+7,581
New +$213K ﹤0.01% 2311